Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Oncovir, Inc. logo — Activating Innate & Adaptive Immunity

Oncovir, Inc.

Activating Innate & Adaptive Immunity

Founded 1998 United States Washington, United States 6 employees Biotechnology, Health Care

General Information

Company Name Oncovir, Inc.
Founded Year 1998
Location United States Washington, United States
Employees 6
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Oncovir, Inc.. To contact Oncovir, Inc., visit oncovir.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Oncovir, Inc. compare?

A PDF of Oncovir, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Oncovir, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Oncovir, Inc.

Oncovir, Inc. is a biotechnology startup founded in 1998, specializing in nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders. The company's slogan, "Activating Innate & Adaptive Immunity," aligns with its core mission of promoting Hiltonol® (poly-ICLC) as an experimental viral mimic and broad activator of innate and adaptive immunity. Initially developed as an interferon inducer, Hiltonol® has shown broader biological effects in humans, including specific antiviral, immune activating, vaccine adjuvant, and antitumor actions. As a pharmaceutical corporation dedicated to advancing therapies in biotechnology and healthcare, Oncovir, Inc. presents an intriguing investment opportunity for venture capitalists seeking to support groundbreaking advancements in medical technology and treatment. Despite the absence of specific details on the company's headquarters, last investment, or associated investors, the innovative approach and potential impact of Oncovir, Inc.'s research and development efforts make it a compelling prospect for potential investment consideration within the biotechnology and healthcare industries.

Business keywords: Pharmaceuticals, Nucleic-Acid-Based Therapies, Cancer Therapies, Immunotherapy, Infectious Disorders, Immune Activation, Vaccine Adjuvant, Antiviral Therapies, Antitumor Actions, Degenerative Disorders, Clinical Therapies, Biological Effects, Interferon Inducer, Viral Mimic, Innate Immunity

No funding data available for Oncovir, Inc. yet.

Oncovir, Inc. Alternatives & Competitors

View All Alternatives
Oncovir, Inc. vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Venture round
7 employees
Biotechnology, Health Care
Oncovir, Inc. vs
Replicor Inc.
Replicor Inc. Canada

292 million people have chronic hepatitis B. We're developing the cure.

6 employees
Biotechnology, Health Care
Oncovir, Inc. vs
Tolerx, Inc.
Tolerx, Inc. United States

Tolerx, Inc., a world leader in immunology, has a portfolio of innovative, first-in-class drug candi...

Venture round
9 employees
Biotechnology, Health Care
View all alternatives

FAQ About Oncovir, Inc.

Activating Innate & Adaptive Immunity
Oncovir, Inc. was founded in 1998.
Oncovir, Inc. is headquartered in Washington, United States.
Oncovir, Inc. operates in Biotechnology and Health Care. Its work centres on Pharmaceuticals, Nucleic-Acid-Based Therapies, Cancer Therapies and Immunotherapy.
Oncovir, Inc. has approximately 6 employees.
Top alternatives and competitors to Oncovir, Inc. include Memgen, Inc., Replicor Inc., Tolerx, Inc., Revitope, Invirsa, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oncovir, Inc. and Memgen, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Oncovir, Inc., https://bouncewatch.com/company/oncovir-inc, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout